Steven Cohen Regeneron Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

$51 Billion
Q3 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 201,499 shares of REGN stock, worth $140 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

201,499

Previous 143,108 40.8%

Holding current value

$140 Million

Previous $75.1 Million 50.8%

% of portfolio

0.22%

Previous 0.17%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$534.91 - $598.71 $31.2 Million - $35 Million	58,391 Added 40.8%	201,499 $113 Million
Q2 2025 Aug 14, 2025	BUY	$483.07 - $625.6 $69.1 Million - $89.5 Million	143,108 New	143,108 $75.1 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $20.2 Million - $24.5 Million	22,871 New	22,871 $24 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $974,277 - $1.19 Million	1,407 New	1,407 $1.16 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $108 Million - $128 Million	-188,700 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $89.2 Million - $105 Million	188,700 New	188,700 $105 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $29.2 Million - $35.3 Million	-53,609 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $26.4 Million - $34.5 Million	53,609 New	53,609 $33.4 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $121 Million - $166 Million	-440,940 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$273.46 - $318.39 $11.7 Million - $13.7 Million	-42,905 Reduced 8.87%	440,940 $122 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $145 Million - $201 Million	483,845 New	483,845 $151 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $62.7 Million - $74.1 Million	-168,644 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $56.6 Million - $68 Million	168,644 New	168,644 $63 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $9.73 Million - $11.3 Million	-27,700 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $48.8 Million - $59.1 Million	-171,400 Reduced 86.09%	27,700 $9.56 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $89.1 Million - $111 Million	-282,254 Reduced 58.64%	199,100 $68.6 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $173 Million - $226 Million	481,354	481,354 $181 Million

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

86.5M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account